The proposed legislation, known as the Ensuring Reproductive Freedom by Shielding Our Providers Act, allows prescribers to request that the prescription label for certain pharmaceuticals, specifically mifepristone and misoprostol, display the name of their health care practice instead of their personal name. This change aims to enhance the privacy and safety of prescribers by protecting their identities in the context of sensitive reproductive health services. Dispensers and pharmacies are required to comply with this request when it is made by the prescriber.

The bill defines key terms such as "dispenser," "pharmacy," and "prescriber," ensuring clarity in its application. It emphasizes the lawful authority of prescribers to distribute these medications and mandates that the requested changes to prescription labels be implemented. The act is set to take effect 30 days after its passage.